|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/11 | |
| A61K 31/21 | |||
| A61K 31/222 | |||
| A61P 27/02 | |||
| A61K 31/215 | |||
| A61K 9/00 | |||
| A61K 47/44 |
| (11) | Number of the document | 2563350 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11771664.7 |
| Date of filing the European patent application | 2011-04-19 | |
| (97) | Date of publication of the European application | 2013-03-06 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2011/001294 |
| Date | 2011-04-19 |
| (87) | Number | WO 2011/132084 |
| Date | 2011-10-27 |
| (30) | Number | Date | Country code |
| 407436 P | 2010-10-27 | US | |
| 325763 P | 2010-04-19 | US | |
| 447611 P | 2011-02-28 | US |
| (72) |
STRONG, H., Andrew, CA
CADDEN, Suzanne, CA
BOCH, Ronald Erwin, CA
|
| (73) |
Retinagenix Therapeutics, Inc.,
421 Kipling Street, Palo Alto, California 94301,
US
|
| (54) | THERAPEUTIC REGIMEN AND METHOD FOR TREATING OR AMELIORATING VISUAL DISORDERS ASSOCIATED WITH AN ENDOGENOUS RETINOID DEFICIENCY |
| THERAPEUTIC REGIMEN AND METHOD FOR TREATING OR AMELIORATING VISUAL DISORDERS ASSOCIATED WITH AN ENDOGENOUS RETINOID DEFICIENCY |